Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
about
Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk.Serum aldosterone and death, end-stage renal disease, and cardiovascular events in blacks and whites: findings from the Chronic Renal Insufficiency Cohort (CRIC) StudyBenefits of Aldosterone Receptor Antagonism in Chronic Kidney Disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to comAldosterone and mortality in hemodialysis patients: role of volume overload.Mild hyponatremia, hypernatremia and incident cardiovascular disease and mortality in older men: A population-based cohort studyCirculating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosisChanges in the perceived epidemiology of primary hyperaldosteronismNon-steroidal anti-inflammatory drug (NSAID) related inhibition of aldosterone glucuronidation and arterial dysfunction in patients with rheumatoid arthritis: a cross-sectional clinical studyRelationship between plasma levels of vasoactive mediators and optic nerve head circulation shown by laser speckle flowgraphy.Ceramide Production Mediates Aldosterone-Induced Human Umbilical Vein Endothelial Cell (HUVEC) Damages.Vitamin D3 therapy corrects the tissue sensitivity to angiotensin ii akin to the action of a converting enzyme inhibitor in obese hypertensives: an interventional study.Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic SubjectsEffect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trialAldosterone and cortisol affect the risk of sudden cardiac death in haemodialysis patients.Aldosterone predicts major adverse cardiovascular events in patients with acute myocardial infarction.The role of the renin-angiotensin system blocking in the management of atrial fibrillation.On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone.Risk factors for renal impairment revealed after unilateral adrenalectomy in patients with primary aldosteronism.Effect of spironolactone on ventricular arrhythmias in patients with left ventricular systolic dysfunction and implantable cardioverter defibrillators.Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone.Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.Aldosterone antagonists in heart failure.The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure.Targeting the aldosterone pathway in cardiovascular disease.Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.Expanding role of mineralocorticoid receptor antagonists in the treatment of heart failure.Estrogen and estrogen receptors in cardiovascular oxidative stress.Diagnosis and management of primary aldosteronism: an updated review.Aldosterone, Renin, Cardiovascular Events, and All-Cause Mortality Among African Americans: The Jackson Heart Study.Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.Positive association between KCNJ5 rs2604204 (A/C) polymorphism and plasma aldosterone levels, but also plasma renin and angiotensin I and II levels, in newly diagnosed hypertensive Chinese: a case-control study.Lower aldosterone-renin ratio is a risk factor for total and cancer death in Japanese individuals: the Takahata study.Effect and mechanism of poly (ADP-ribose) polymerase-1 in aldosterone-induced apoptosisAldosterone breakthrough during angiotensin receptor blocker use: more questions than answers?The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.Effects of Candesartan on Left Ventricular Function, Aldosterone and BNP in Chronic Heart Failure.C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction.Role and Regulation of MicroRNAs in Aldosterone-Mediated Cardiac Injury and Dysfunction in Male Rats.
P2860
Q33590710-3FB2EFF1-BE36-4766-AE52-16EAC06C7E2EQ33871492-C2C471D4-65C4-4396-8D9D-B6B232D04AB0Q33960590-C3B1FF5B-CC0B-446B-A5B2-3DC5A7A7FC85Q34612156-E2BEDEDE-DE68-4246-A677-ACEED83A9767Q34672460-8CDEDECA-BD08-425D-B396-914BA011DF3EQ34714245-527BF261-B603-4C9D-9A35-A0489A87D571Q35055052-DD8646BB-C488-4D93-9474-4E0F946BFE38Q35151575-F1F1134F-A977-46B5-A137-69E1E5B558DBQ35320084-56FD5604-11DA-4A10-BCDC-1508BAA7CD49Q35761780-BF62ABD4-A98C-42F6-A7A7-C040BF93A3C9Q35898784-C1EFADA9-2D03-420C-828E-B7E44A96A7ADQ36069813-1BD8A026-3DEB-43EB-94F4-D715FC8A2B69Q36271369-56411560-BD22-4DEA-B2FC-FB74F1B97CF6Q36448508-B09B5D44-245D-415C-8AB1-F5C7112134F0Q36626365-9371735F-517E-4D17-ADD3-99B348CCCB3AQ36800757-010FBCCF-610B-4BB4-A3E5-49EB54ED0AAAQ37166906-F79C6D14-F04C-42BF-BFD8-BB4482FA6CC1Q37260954-6CD425AC-1AB0-4C75-814F-EC033C63272FQ37327876-08F37E9F-DB70-4E1D-9E3C-7994E384505AQ37387619-23D3771E-9694-4221-861E-22CB9EC1D390Q37502129-1D71183F-CFAA-4D24-B270-D63A537026FEQ37592818-D6399E61-6EF6-4D3B-9F93-CDF5260C69C3Q37821172-A9CAC57A-465C-48F0-A4C2-F15D688E7D7EQ37945452-3180C1CD-4BAE-4D1D-9BEE-7E4D01B39C5BQ37951665-49801C96-F9B9-490D-AA51-70BC87DEF7E1Q37984036-B943CDE5-9054-49E3-B5D6-CFCA9C97D5ABQ38040730-B8174637-3A04-491F-8449-FE022D8F98CFQ38082442-9FA32803-E19C-4674-BAC1-84EA68DD8C99Q38108818-4A123B7A-5F05-45C9-B900-BC664FFE94BBQ38617536-82D48A14-9C47-4F70-8FF8-4C1F7EAABEAAQ38815486-AB76E469-651F-4837-A14F-8EC222C600A2Q39013005-AF1A57E1-36E2-48BC-AA10-62374B4F8797Q41717263-7C2A4423-C923-42B1-AAD0-C2FEF4DC2DE7Q41887087-CFD34B5B-BC5C-400C-8EAB-8E5BADFB0FF5Q42959024-12DED140-2FD5-4F27-B9E6-31F1109C8F7BQ48182641-5CF36E34-9B97-4D08-8ADD-E9D4D75C18E0Q48678090-B1BDB55F-D336-4171-94F4-BA396E53BB51Q48787655-CA635324-6ABB-424F-A2E3-3260B0732939Q48882910-B1508591-8624-4DE7-8965-90AFD15EF4C9Q50756676-065DD6D7-4FB3-4470-BCFA-8017026D749F
P2860
Plasma aldosterone levels are associated with increased cardiovascular mortality: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Plasma aldosterone levels are ...... vascular Health (LURIC) study.
@en
Plasma aldosterone levels are ...... Risk and Cardiovascular Health
@nl
type
label
Plasma aldosterone levels are ...... vascular Health (LURIC) study.
@en
Plasma aldosterone levels are ...... Risk and Cardiovascular Health
@nl
prefLabel
Plasma aldosterone levels are ...... vascular Health (LURIC) study.
@en
Plasma aldosterone levels are ...... Risk and Cardiovascular Health
@nl
P2093
P2860
P356
P1476
Plasma aldosterone levels are ...... vascular Health (LURIC) study.
@en
P2093
Andreas Meinitzer
Andreas Tomaschitz
Bernhard O Boehm
Eberhard Ritz
Stefan Pilz
P2860
P304
P356
10.1093/EURHEARTJ/EHQ019
P577
2010-03-02T00:00:00Z